Percutaneous Cryoablation vs Partial Nephrectomy: Cost Comparison of T1a Tumors

被引:25
作者
Chehab, Monzer [1 ]
Friedlander, Joshua A. [1 ]
Handel, Jeremy [1 ]
Vartanian, Stephen [1 ]
Krishnan, Anant [2 ]
Wong, Ching-yee Oliver [2 ]
Korman, Howard [3 ]
Seifman, Brian [3 ]
Ciacci, Joseph [1 ]
机构
[1] Oakland Univ, William Beaumont Sch Med, Dept Radiol, 3601 W Thirteen Mile Rd, Royal Oak, MI 48073 USA
[2] Oakland Univ, William Beaumont Sch Med, Dept Diagnost & Intervent Radiol, Royal Oak, MI USA
[3] Oakland Univ, William Beaumont Sch Med, Urol, Royal Oak, MI USA
关键词
RENAL-CELL CARCINOMA; RADIOFREQUENCY ABLATION; RADIOLOGY; OPTIONS;
D O I
10.1089/end.2015.0183
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: To compare cost of percutaneous cryoablation vs open and robot-assisted partial nephrectomy of T1a renal masses from the hospital perspective. Materials and Methods: We retrospectively compared cost, clinical and tumor data of 37 percutaneous cryoablations to 26 open and 102 robot-assisted partial nephrectomies. Total cost was the sum of direct and indirect cost of procedural and periprocedural variables. Clinical data included demographics, Charlson Comorbidity Index (CCI), hospitalization time, complication rate, ICU admission rate, and 30-day readmission rates. Tumor data included size, RENAL nephrometry score, and malignancy rate. Student's t-test was used for continuous variables and Fisher's exact or chi-square tests for categorical data. Results: Mean total cost was lower for percutaneous cryoablation than open or robot-assisted partial nephrectomy: $6067 vs $11392 or $11830 (p<0.0001) with lower cost of procedure room: $1516 vs $3272 or $3254 (p<0.0001), room and board: $95 vs $1907 or $1106 (p<0.0001), anesthesia: $684 vs $1223 or $1468 (p<0.0001), and laboratory/pathology fees: $205 vs $804 or $720 (p<0.0001). Supply and device cost was higher than open: $2596 vs $1352 (p<0.0001), but lower than robot-assisted partial nephrectomy: $3207 (p=0.002). Mean hospitalization times were lower for percutaneous cryoablation (p<0.0001), while age and CCI were higher (p<0.0001). No differences in tumor size, nephrometry score, malignancy rate complication, ICU, or 30-day readmission rates were observed. Conclusion: Percutaneous cryoablation can be performed at significantly lower cost than open and robotic partial nephrectomies for similar masses.
引用
收藏
页码:170 / 176
页数:7
相关论文
共 31 条
  • [21] Comparison of percutaneous and surgical approaches to renal tumor ablation: Metaanalysis of effectiveness and complication rates
    Hui, Gladwin C.
    Tuncali, Kemal
    Tatli, Servet
    Morrison, Paul R.
    Silverman, Stuart G.
    [J]. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2008, 19 (09) : 1311 - 1320
  • [22] Laydner H, 2013, UROLOGY, V81, P533, DOI 10.1016/j.urology.2012.07.104
  • [23] Cost analysis of open, laparoscopic, and percutaneous treatment options for nephron-sparing surgery
    Link, Richard E.
    Permpongkosol, Sompol
    Gupta, Ajay
    Jarrett, Thomas W.
    Solomon, Stephen B.
    Kavoussi, Louis R.
    [J]. JOURNAL OF ENDOUROLOGY, 2006, 20 (10) : 782 - 789
  • [24] Costing and Perspective in Published Cost-Effectiveness Analysis
    Neumann, Peter J.
    [J]. MEDICAL CARE, 2009, 47 (07) : S28 - S32
  • [25] Radiofrequency ablation versus nephron-sparing surgery for small unilateral renal cell carcinoma: Cost-effectiveness analysis
    Pandharipande, Pari V.
    Gervais, Debra A.
    Mueller, Peter R.
    Hur, Chin
    Gazelle, G. Scott
    [J]. RADIOLOGY, 2008, 248 (01) : 169 - 178
  • [26] RENAL Nephrometry Scoring System: The Radiologist's Perspective
    Parsons, Rosaleen B.
    Canter, Daniel
    Kutikov, Alexander
    Uzzo, Robert G.
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2012, 199 (03) : W355 - W359
  • [27] What Is Value in Health Care?.
    Porter, Michael E.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (26) : 2477 - 2481
  • [28] Health Care 2009: A Strategy for Health Care Reform - Toward a Value-Based System.
    Porter, Michael E.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (02) : 109 - 112
  • [29] Prospective Analysis of the Safety and Efficacy of Percutaneous Cryoablation for pT1NxMx Biopsy-Proven Renal Cell Carcinoma
    Rodriguez, Ronald
    Cizman, Ziga
    Hong, Kelvin
    Koliatsos, Alexandra
    Georgiades, Christos
    [J]. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2011, 34 (03) : 573 - 578
  • [30] Cost-effectiveness analysis in radiology
    Singer, ME
    Applegate, KE
    [J]. RADIOLOGY, 2001, 219 (03) : 611 - 620